Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06344065
What this trial is testing

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Who this might be right for
Healthy Volunteers
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 1,584
Large-scale testing (Phase 3)Active Not RecruitingNCT05141721
What this trial is testing

A Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Seattle Project Corporation 700
Early research (Phase 1)WithdrawnNCT03166254
What this trial is testing

Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNSCLCNon-small Cell Lung Cancer+1 more
Washington University School of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT04936529
What this trial is testing

A Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 286
Testing effectiveness (Phase 2)Ended earlyNCT03300362
What this trial is testing

Improved Novel VaccIne CombinaTion InflUenza Study

Who this might be right for
Influenza
Barinthus Biotherapeutics 862
Large-scale testing (Phase 3)Study completedNCT01457508
What this trial is testing

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type b (Hib)+3 more
GlaxoSmithKline 440
Early research (Phase 1)Study completedNCT05987488
What this trial is testing

ShigETEC Vaccine Study in Bangladesh

Who this might be right for
Healthy Volunteers
Eveliqure Biotechnologies GmbH 196
Post-approval studies (Phase 4)UnknownNCT05298800
What this trial is testing

Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23

Who this might be right for
SafetyImmunogenicity, VaccineCOVID-19 Vaccines+2 more
Centers for Disease Control and Prevention, China 3,000
Testing effectiveness (Phase 2)WithdrawnNCT03167164
What this trial is testing

QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy

Who this might be right for
Merkel Cell Carcinoma
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Study completedNCT00617409
What this trial is testing

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

Who this might be right for
Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 69
Early research (Phase 1)Study completedNCT00662272
What this trial is testing

Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant

Who this might be right for
Influenza
Colby Pharmaceutical Company 128
Testing effectiveness (Phase 2)Study completedNCT01739036
What this trial is testing

A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 48
Testing effectiveness (Phase 2)Ended earlyNCT00677612
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer
Tokyo University 14
Large-scale testing (Phase 3)Study completedNCT00197119
What this trial is testing

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Who this might be right for
Hepatitis BHepatitis A
GlaxoSmithKline 244
Large-scale testing (Phase 3)Study completedNCT00969436
What this trial is testing

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 450
Early research (Phase 1)Study completedNCT06550830
What this trial is testing

Clinical Trial of PCV24 in Children Aged 2-17 Years

Who this might be right for
Pneumococcal Infectious Disease
Sinovac Life Sciences Co., Ltd. 119
Testing effectiveness (Phase 2)UnknownNCT03715985
What this trial is testing

Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)

Who this might be right for
Malignant Melanoma, MetastaticNon Small Cell Lung Cancer MetastaticBladder Urothelial Carcinoma, Metastatic
Herlev Hospital 12
Early research (Phase 1)WithdrawnNCT05430958
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Who this might be right for
Coronavirus Infection
Inovio Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00406211
What this trial is testing

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

Who this might be right for
RubellaVaricellaMumps+1 more
GlaxoSmithKline 398
Testing effectiveness (Phase 2)Active Not RecruitingNCT05108870
What this trial is testing

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Who this might be right for
Human Papilloma VirusHPVHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Chicago 35
Next Page